Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 638

Results For "THA"

8044 News Found

IQVIA launches OCE+ to deliver AI-driven customer engagement
Digitisation | March 16, 2022

IQVIA launches OCE+ to deliver AI-driven customer engagement

OCE+ uses IQVIA’s industry-leading data and advanced analytics to deliver AI-driven recommendations directly into the daily workflows of life sciences commercial teams


Oppilotech and Evariste technologies partner for anti-bacterial programme
Biotech | March 16, 2022

Oppilotech and Evariste technologies partner for anti-bacterial programme

Machine learning approach to systems biology combined with ligand discovery platform


Onco aims to make cancer care affordable
Healthcare | March 16, 2022

Onco aims to make cancer care affordable

Onco Care Plus is available at just INR 399 per month, and provides services like free doctor consultation, 15% off on cancer treatment costs, 25% off for diagnostic tests, free nutrition plans, among many more


SRL Diagnostics and Roche Diagnostics partner to establish an integrated lab
Clinical Trials | March 16, 2022

SRL Diagnostics and Roche Diagnostics partner to establish an integrated lab

Empowers the lab to do more in less time within the existing floor plan by integrating clinical chemistry and immunoassay testing onto a single platform


NuclixBio and PharmAbcine sign collaborative research agreement
Biotech | March 15, 2022

NuclixBio and PharmAbcine sign collaborative research agreement

Under the agreement, both companies will conduct collaborative research utilizing NuclixBio's proprietary circular mRNA platform named 'ringRNA’ to develop novel mRNA therapeutics that can generate PharmAbcine's antibodies


Single-cell DNA sequencing identifies genetic mechanism in brain lesion formation
Biotech | March 15, 2022

Single-cell DNA sequencing identifies genetic mechanism in brain lesion formation

Tapestri Platform powers Nature Cardiovascular Research publication that identifies two somatic mutations associated with sporadic brain blood vessel disorder


Spectrum Chemical launches products for vaccines, therapeutics and biopharmaceuticals
Biotech | March 15, 2022

Spectrum Chemical launches products for vaccines, therapeutics and biopharmaceuticals

A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing


I Peace triples GMP cell manufacturing by expanding CDMO facility
Biotech | March 15, 2022

I Peace triples GMP cell manufacturing by expanding CDMO facility

The facility registration, along with DMF registration and GMP certification provides peace of mind to clients looking to use our iPSCs for clinical and commercial use in the United States, Japan, and other global markets


USFDA grants Orphan Drug Designation for Akantior
Biotech | March 15, 2022

USFDA grants Orphan Drug Designation for Akantior

SIFI is currently evaluating various options for the commercialization of Akantior (polihexanide) globally, including potential out-license agreements outside its core markets


Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments
News | March 15, 2022

Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments

Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective January 1, 2023